Nightstar Therapeutics PLC ADR (NITE)

Sector:
HEALTH CARE
Industry:
PHARMACEUTICALS
SIC:
BIOLOGICAL PRODUCTS, (NO DISGNOSTIC SUBSTANCES)
CEO:
N/A
Employees:
47
C/O NIGHTSTAR, INC., 203 CRESCENT STREET, SUITE 303, WALTHAM, MA 02453
781-778-7553

*** This stock is shown as delisted in our database. *** If you think this isn't correct then please let us know

N/A

Data derived from most recent annual or quarterly report
Market Cap 714.021 Million Shares Outstanding28.1 Million Avg 30-day Volume 189.376 Thousand
P/E Ratio0.0 Dividend Yield0.0 EPS-2.15
Price to Revenue31.4986 Debt to Equity0.0 EBITDA-33.382 Million
Price to Book Value2.6665 Operating Margin-358.9646 Enterprise Value217.946 Million
Current Ratio7.516 EPS Growth0.721 Quick Ratio6.953
1 Yr BETA 52-week High/Low 0.0 / Profit Margin-363.205
Operating Cash Flow Growth-45.7097 Altman Z-Score13.1882 Free Cash Flow to Firm -55.319 Million
View SEC Filings from NITE instead.

View recent insider trading info

Funds Holding NITE (via 13F filings)

Refresh Download CSV Download Excel (.xlsx) Download TSV
Filter by:
to
to
to
Refresh
*Shares are split adjusted
*Please note that if a filer hasn't submitted a 13F filing for a quarter then the filer's shares will be listed as "Sold All"

Mutual Funds Holding NITE BETA

Active Schedule 13D and 13G filings

Please sign in first

Open Market Buys/Sells Last 60 Days

Open Market Buys (P)

none

Open Market Sells (S)

none

Exercise Derivative Conversion (M)

none

Current/Former Insiders

Insider Name Type Last Reported Shares Held Last Reported Date Filings in past year

NEW ENTERPRISE ASSOCIATES 15, L.P.

MAKHZOUMI MOHAMAD

SONSINI PETER W.

BARRIS PETER J

MAKOWER JOSHUA

SANDELL SCOTT D

BASKETT FOREST

FLORENCE ANTHONY A. JR.

NEA 15 GP, LLC

NEA PARTNERS 15, L.P.

  • 10% Owner
No longer subject to file 2019-06-07 0

FELLOWS DAVID A CHIEF EXECUTIVE OFFICER

  • Officer
  • Director
0 2019-06-07 0

MOTT DAVID M

  • Director
  • 10% Owner
No longer subject to file 2019-06-07 0

WHITCUP SCOTT M

  • Director
0 2019-06-07 0

LUBNER DAVID CHARLES

  • Director
0 2019-06-07 0

ONG TUYEN CHIEF DEVELOPMENT OFFICER

  • Officer
0 2019-06-07 0

SYNCONA PORTFOLIO LTD

SYNCONA HOLDINGS LTD

SYNCONA LTD

SYNCONA INVESTMENT MANAGEMENT LTD

  • 10% Owner
No longer subject to file 2019-06-07 0

ROBINSON GREGORY SCOTT CHIEF SCIENTIFIC OFFICER

  • Officer
0 2019-06-07 0

SUNDARAM SENTHIL VEL CHIEF FINANCIAL OFFICER

  • Officer
0 2019-06-07 0

HOLLOWOOD CHRISTOPHER J

  • Director
0 2019-06-07 0

MCARTHUR JAMES G

  • Director
0 2019-06-07 0

COBB PAULA K

  • Director
0 2019-06-07 0

YOON SEOKHO BRYAN GENERAL COUNSEL AND SECRETARY

  • Officer
0 2019-06-06 0

ROBINSON GREGORY SCOTT CHIEF SCIENTIFIC OFFICER

ROBINSON GREGORY SCOTT CHIEF SCIENTIFIC OFFICER

  • Officer
0 2019-01-22 0

SYNCONA PORTFOLIO LTD

SYNCONA HOLDINGS LTD

SYNCONA LTD

  • 10% Owner
13,203,922 2019-01-01 0

Insider Transactions Last 60 Days

Reporting Owners Filing Date Trans Date Trans Code Shares Share Price Acquired
Disposed
Shares Owned after D/I 10b5 Perf 1d* Perf 5d* Perf 1m* Max Gain Max Gain Days Max Loss Max Loss Days
No current insider transactions

* -

Transaction Code Definitions
Code Definition
A Grant, award or other acquisition pursuant to Rule 16b-3(d)
C Conversion of derivative security
D Disposition to the issuer of issuer equity securities pursuant to Rule 16b-3(e)
E Expiration of short derivative position
F Payment of exercise price or tax liability by delivering or withholding securities incident to the receipt, exercise or vesting of a security issued in accordance with Rule 16b-3
G Bona fide gift
H Expiration (or cancellation) of long derivative position with value received
I Discretionary transaction in accordance with Rule 16b-3(f) resulting in acquisition or disposition of issuer securities
J Other acquisition or disposition
L Small acquisition under Rule 16a-6
M Exercise or conversion of derivative security exempted pursuant to Rule 16b-3
O Exercise of out-of-the-money derivative security
P Open market or private purchase of non-derivative or derivative security
S Open market or private sale of non-derivative or derivative security
U Disposition pursuant to a tender of shares in a change of control transaction
W Acquisition or disposition by will or the laws of descent and distribution
X Exercise of in-the-money or at-the-money derivative security
Z Deposit into or withdrawal from voting trust

IBR Securities Loan Availability

Updated throughout the day, this shows the number of shares available to borrow. Data provided by Interactive Brokers

Security Date/Time Rebate Rate Fee Rate Shares Available

Current Active Short Positions

Holder Issuer Net Short Position Position Date Origin

Elevate your investments